Cargando…
An Update on the Molecular and Cellular Basis of Pharmacotherapy in Type 2 Diabetes Mellitus
Diabetes mellitus (DM) is a chronic illness with an increasing global prevalence. More than 537 million cases of diabetes were reported worldwide in 2021, and the number is steadily increasing. The worldwide number of people suffering from DM is projected to reach 783 million in 2045. In 2021 alone,...
Autores principales: | Mahgoub, Mohamed Omer, Ali, Ifrah Ismail, Adeghate, Jennifer O., Tekes, Kornélia, Kalász, Huba, Adeghate, Ernest A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10253663/ https://www.ncbi.nlm.nih.gov/pubmed/37298274 http://dx.doi.org/10.3390/ijms24119328 |
Ejemplares similares
-
Medicinal Chemistry and Applications of Incretins and DPP-4 Inhibitors in the Treatment of Type 2 Diabetes Mellitus
por: Lotfy, Mohamed, et al.
Publicado: (2011) -
Amylin Analogues in the Treatment of Diabetes Mellitus: Medicinal Chemistry and Structural Basis of its Function
por: Adeghate, Ernest, et al.
Publicado: (2011) -
Medicinal Chemistry and Actions of Dual and Pan PPAR Modulators
por: Adeghate, Ernest, et al.
Publicado: (2011) -
Pharmacokinetics of Two Chlorine-Substituted Bis-Pyridinium Mono-Aldoximes with Regenerating Effect on Butyrylcholinesterase
por: Kalász, Huba, et al.
Publicado: (2020) -
Nociceptin Increases Antioxidant Expression in the Kidney, Liver and Brain of Diabetic Rats
por: Adeghate, Ernest, et al.
Publicado: (2021)